Astria Therapeutics Shares Are Trading Higher After the Company Announced Initial Proof-of-concept Results From the ALPHA-STAR Phase 1b/2 Clinical Trial Evaluating STAR-0215 in HAE Patients
Astria Therapeutics 公佈了評估 HAE 患者中 STAR-0215 的 ALPHA-STAR 1b/2 期臨床試驗的初步概念驗證結果後,該公司股價走高